14 December 2017

Kees Kramers is the first Professor of Medication Safety to be appointed in Nijmegen. In the past there has been a long time close collaboration between physicians and pharmacists in Nijmegen. This collaboration is a prerequisite for medication safety.



Where and when were you born?

Dirksland (Goeree Overflakkee); January 6th, 1962.
Where do you live and with whom?
Groesbeek, with Professor Heijdra.
Who was your role model when you were a kid?
My teacher chemistry (who made apple wine with us and distilled undrinkable calvados out of it)
Why aren’t you doing the same thing now as your role model (or do you?)
I am a teacher!
What is the thing in your (work or other) history that you are most proud of?
The obligatory national Pharmacotherapy end test for student just before becoming physician.
What is it that you would like to achieve in work in the next 5 to 10 years?
A tool to reduce hyperpolypharmacy in frail elderly.
For what can we wake you up?
A severe (complex) intoxication.
What is your hobby and how good are you at it?
Cabaret, and I’m too modest to express in public how good I am.
What is your biggest irritation?
People who take themselves too serious.
Who would you like to invite for dinner, if you had the chance?
Bill Clinton.
 

Related news items


The new front line: big data podcast

22 May 2020

What role do big data and technology play in the fight against corona? What data can help save lives? How do you ensure that your personal health data is used safely? Among others, Peter-Bram 't Hoen explains.

read more

OARSI Basic Science Award for Peter van der Kraan

22 May 2020

Purpose of this Basic Science Award of the Osteoarthritis Research Society International (OARSI) is to stimulate fundamental research in the field of osteoarthritis.

read more

Evaluation of an AI system for detection of COVID-19 on Chest X-Ray images

22 May 2020

In the journal Radiology RIHS researcher Keelin Murphy described how an artificial intelligence system (CAD4COVID-XRay) can identify characteristics of COVID-19 on chest x-rays with performance comparable to six independent radiologists.

read more

First clinical trial with genetically modified malaria vaccine completed

22 May 2020

In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite. The results of this clinical trial, published in Science Translational Medicine, show that the vaccine is safe and elicits a defense response against a malaria infection.

read more

New step in the development of a vaccine against malaria

22 May 2020

A new vaccine based on rodent malaria parasites achieved a 95% reduction in infection of the liver in humans. An international consortium publishes the results in Science Translational Medicine.

read more

Intra-articular corticosteroid injections increase the risk of requiring knee arthroplasty

14 May 2020

In The Bone & Joint Journal, RIHS researcher Stan Wijn et al. showed that corticosteroid injections in the knee joint are associated with an increased risk of knee arthroplasty in patients with, or at risk of developing, symptomatic osteoarthritis of the knee.

read more